Cargando…
The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation
Renal transplantation is the definitive therapy for patients suffering from end-stage renal disease. Though there have been significant advances in immunosuppression in these patients, there is still up to 30% acute and subclinical rejection. Current standards employ lab markers of renal function an...
Autores principales: | Kueht, Michael L., Dongur, Laxmi Priya, Cusick, Matthew, Stevenson, Heather L., Mujtaba, Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605518/ https://www.ncbi.nlm.nih.gov/pubmed/36294839 http://dx.doi.org/10.3390/jpm12101700 |
Ejemplares similares
-
Antibody Therapeutics as Interfering Agents in Flow Cytometry Crossmatch for Organ Transplantation
por: Kueht, Michael L., et al.
Publicado: (2023) -
Kidney Allograft Monitoring by Combining Donor-Derived Cell-Free DNA and Molecular Gene Expression: A Clinical Management Perspective
por: Rizvi, Asim, et al.
Publicado: (2023) -
Donor-directed immunologic safety of COVID-19 vaccination in renal transplant recipients
por: Kueht, Michael, et al.
Publicado: (2022) -
Multisite biologic tissue SARS-CoV-2 PCR testing in kidney transplantation from a COVID-positive donor
por: Zhang, Jared R, et al.
Publicado: (2022) -
Intra-operative kinetics of anti-HLA antibody in simultaneous liver-kidney transplantation
por: Kueht, M., et al.
Publicado: (2021)